The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human clinical trial with intratumoral BO-112 in solid malignancies: A novel immunotherapy based in double-stranded RNA (dsRNA).
 
Ivan Marquez Rodas
Consulting or Advisory Role - Amgen; Bioncotech; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Maria E. Rodriguez-Ruiz
No Relationships to Disclose
 
Sara Lopez-Tarruella
Honoraria - Roche
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Celgene; Pierre Fabre; Roche
 
Jose Luis Perez-Gracia
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Speakers' Bureau - Bristol-Myers Squibb; Roche
Research Funding - Merck; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Enrique de Miguel
No Relationships to Disclose
 
Aitana Calvo
No Relationships to Disclose
 
Montserrat Blanco-Codesido
No Relationships to Disclose
 
Salvador Martin-Algarra
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - MSD
 
Miguel Martin
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst)
 
Ignacio Melero
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; Lilly; Roche
Research Funding - Bristol-Myers Squibb; Pfizer; Roche
Travel, Accommodations, Expenses - Genentech; Roche